EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 06 May 2021

EFPIA statement on IP waiver for COVID-19 vaccines

While we wholeheartedly agree with the goal of protecting citizens around the world through vaccines, waiving patents will make winning the fight against the coronavirus even harder.

Speaking about the US administration’s decision to support a proposal to waive patents on COVID-19 vaccines, EFPIA Director General Nathalie Moll said. “This short-sighted and ineffectual decision by the Biden administration puts the hard-won progress in fighting this terrible disease in jeopardy. While we wholeheartedly agree with the goal of protecting citizens around the world through vaccines, waiving patents will make winning the fight against the coronavirus even harder.”
Read more

News

EFPIA response to the publication of the updated EU Industrial Strategy
06 May 2021

The EU pharmaceutical strategy should be aligned with the industrial strategy and focused on ensuring that Europe remains... Read more

EFPIA statement on the EU Strategy on COVID Therapeutics
06 May 2021

There are currently nearly 3000 clinical trials exploring therapeutics for treating COVID patients and around 61 therapeutic... Read more

Coming together to create faster, more equitable access to medicines across Europe
30 April 2021

Addressing Healthcare Challenges: Principles on the Transparency of Evidence from Novel Pricing and Payment Models Read more

19 Conversations | The EFPIA Podcast Series

Podcast: How can we improve healthcare access for marginalised communities?
05 May 2021

Welcome to 19 conversations Read more

Podcast: What value do Public Private Partnerships bring for society?
30 April 2021

Welcome to 19 conversations Read more

EFPIA 2021 Connecting Healthcare Awards

Meet the project winners of the Connecting Healthcare Innovation Award: The Dreamcatcher, in our video interview:

Events

Unlocking the potential of the European Health Data Space to improve diabetes management in...
25 May 2021 (Virtual event)

The first in a two-part series co-hosted by the EFPIA Diabetes Platform and the European Diabetes Forum (EUDF) Read more

Unlocking the power of health data: the promise of the European Health Data Space
10 June 2021 (Virtual event)

A virtual event hosted by EFPIA and MedTech Europe Read more

Why are you #TeamVaccines?

Watch the latest #TeamVaccines videos on the Vaccines Europe website here and find out why we are all on #TeamVaccines:

What we are reading

Industry weary of waiving vaccine patents
On 06 May 2021 (DW.com)

Nathalie Moll from EFPIA says, "Sharing excess production and supporting the COVAX program are faster ways to get COVID-19... Read more

Using data to raise awareness and initiate action to improve outcomes for people with diabetes...
On 06 May 2021 (EUDF)

Viewpoint story by Robert Heine, Chair EUDF Data & Registries Strategic Forum. Read more

Commission aims to roll out COVID-19 travel certificates by June
On 03 May 2021 (Euractiv)

The majority of EU countries should be technically ready for COVID-19 certificates by the first week of June ahead of... Read more

Waiving IP rules will not deliver more Covid vaccines
On 25 May 2021 (Financial Times)

Scaling up manufacturing is the best way to inoculate the world and end the pandemic, write Thomas Cueni, IFPMA Director... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu